Systems for treating skin laxity

Patent metadata

Field	Value
Publication number	US-9694211-B2
Application number	US-201615248407-A
Country	US
Kind code	B2
Filing date	Aug 26, 2016
Priority date	Oct 6, 2004
Publication date	Jul 4, 2017
Grant date	Jul 4, 2017

Abstract

A system and method for ultrasound treatment of skin laxity are provided. Systems and methods can include ultrasound imaging of the region of interest for localization of the treatment area, delivering ultrasound energy at a depth and pattern to achieve the desired therapeutic effects, and/or monitoring the treatment area to assess the results and/or provide feedback. In an embodiment, a treatment system and method can be configured for producing arrays of sub-millimeter and larger zones of thermal ablation to treat the epidermal, superficial dermal, mid-dermal and deep dermal components of tissue.

First claim

What is claimed is:

1. An ultrasound system for treatment of skin laxity, the system comprising:
an ultrasound probe comprising a housing, wherein the housing comprises a motion mechanism and an ultrasound transducer,
wherein the ultrasound transducer comprises a therapy component,
wherein the therapy component consists of:
a single active focused ultrasound therapy element,
wherein the ultrasound therapy element is configured to provide a single mechanical focus,
wherein the single mechanical focus is configured to provide ultrasound therapy energy in a form of a single thermal focus in a tissue at a depth below a skin surface,
wherein the depth is a single, fixed depth in a range of up to 5 mm below the skin surface to treat the tissue,

wherein the tissue comprises a combination of any of the group consisting of: an epidermal tissue, a superficial dermal tissue, a mid-dermal tissue, a deep dermal tissue, a muscle tissue, and an adipose tissue,
wherein the single thermal focus is formed without electronic focusing and without a lens,

wherein a portion of the ultrasound probe is configured for acoustic coupling to the skin surface;
a control system connected to the motion mechanism and the ultrasound therapy element;
an input device connected to the control system; and
a power supply connected to the control system;
wherein the ultrasound therapy element is configured for delivery of energy at a temperature sufficient to tighten at least a portion of the tissue at the depth under the skin surface,
wherein the ultrasound therapy element is connected to the motion mechanism,
wherein the motion mechanism moves the ultrasound therapy element to form a plurality of thermal lesions at the depth for tighten at least a portion of the tissue for reducing an appearance of skin laxity.

2. The system of claim 1 , wherein the ultrasound therapy element is configured to increase the temperature of the tissue in the region of interest to greater than 60° C.

3. The system of claim 1 , further comprising a monitoring system,
wherein the monitoring system is configured to monitor a treatment parameter, wherein the treatment parameter measured comprises a temperature of the tissue below the skin surface,
wherein the housing further comprises a temperature monitoring sensor,
wherein the therapy element is a single element that delivers ultrasound energy at a frequency of between 2 MHz to 25 MHz.

4. The system of claim 1 , wherein the housing contains a temperature monitoring sensor,
wherein the control system comprises a processor, software, and a communication device,
wherein the ultrasound probe is connected to the control system via a cable,
wherein the processor relays data from the temperature monitoring sensor via the communication device.

5. The system of claim 1 ,
wherein the motion mechanism comprises an encoder and the ultrasound therapy energy is configured to deliver an energy level for causing at least one of shrinking collagen and denaturing the tissue in the region of interest under a wrinkle,
wherein the therapy element delivers the ultrasound therapy energy at a frequency of between 2 MHz to 25 MHz.

6. The system of claim 1 , wherein the control system comprises a spatial control and a temporal control,
wherein the spatial control and the temporal control are configured for controlling the delivery of energy at a temperature sufficient to cause denaturation of at least the portion of the tissue at the depth under the skin surface,
wherein the spatial control and the temporal control are configured for controlling the delivery of energy at a frequency of between 2 MHz to 25 MHz.

7. An ultrasound system for treatment of skin laxity, the system comprising:
an ultrasound probe configured for delivery of an ultrasound therapy energy at a temperature sufficient to heat at least a portion of a tissue at a depth under a skin surface,
wherein the tissue comprises a combination of any of the group consisting of: an epidermal tissue, a superficial dermal tissue, a mid-dermal tissue, a deep dermal tissue, a muscle tissue, and an adipose tissue; and
a control system;
wherein the ultrasound probe comprises a housing, wherein the housing comprises an ultrasound transducer,
wherein the ultrasound transducer comprises a therapy component,
wherein the therapy component consists of:
a single active ultrasound therapy element,
wherein the single active ultrasound therapy element is configured to provide a single mechanical focus,
wherein the single mechanical focus is configured to provide ultrasound therapy energy in the form of a single thermal focus in the tissue at a depth below a skin surface,
wherein the single thermal focus is formed without electronic focusing and without a lens,

wherein the ultrasound therapy element is in communication with the control system,
wherein the ultrasound therapy element is configured for delivery of the ultrasound therapy energy at the temperature sufficient to heat the at least a portion of the tissue at the depth under the skin surface,
wherein the ultrasound probe forms a plurality of thermal lesions at the depth for reducing the appearance of skin laxity.

8. The system of claim 7 , wherein the region of interest comprises the tissue, wherein the skin surface comprises a wrinkle, and wherein the plurality of thermal lesions tightens the tissue.

9. The system of claim 7 , further comprising a monitoring system,
wherein the monitoring system is configured to monitor a treatment parameter, wherein the treatment parameter measured comprises a temperature of the tissue below the skin surface,
wherein the housing further comprises a temperature monitoring sensor, wherein the ultrasound therapy element delivers the ultrasound therapy energy at a frequency of between 2 MHz to 75 MHz.

10. The system of claim 7 , wherein the ultrasound probe is connected to the control system via a cable, and wherein the control system comprises:
a communication device;
a processor, software, an input device, and a power supply.

11. The system of claim 7 ,
wherein the ultrasound therapy element is a single element that delivers the ultrasound therapy energy at a frequency of between 2 MHz to 25 MHz, wherein the ultrasound therapy element is configured to increase the temperature of the tissue in the region of interest to greater than 60° C.

12. An ultrasound system for treatment of skin laxity, the system comprising:
an ultrasound probe comprising a housing, wherein the housing comprises an ultrasound transducer,
wherein the ultrasound transducer comprises a therapy component,
wherein the therapy component consists of:
a single active focused ultrasound therapy element,
wherein the ultrasound therapy element is configured to provide a single mechanical focus,
wherein the single mechanical focus is configured to provide ultrasound therapy energy in the form of a single thermal focus in a tissue at a depth below a skin surface,
wherein the depth is up to 5 mm below the skin surface,
wherein the tissue comprises a combination of any of the group consisting of: an epidermal tissue, a superficial dermal tissue, a mid-dermal tissue, a deep dermal tissue, an adipose tissue, and a muscle tissue,
wherein the single thermal focus is formed without electronic focusing and without a lens, and

a control system comprising a processor and power supply;
wherein the ultrasound therapy element is in communication with the control system,
wherein the ultrasound therapy element is configured for delivery of the ultrasound therapy energy at a temperature sufficient to denature at least a portion of the tissue in the

Assignees

• Guided Therapy Systems Llc

Inventors

• Barthe Peter G
• Slayton Michael H
• Makin Inder Raj S

Classifications

• A61N2007/027

  with multiple foci created simultaneously · CPC title

• A61B8/483

  involving the acquisition of a 3D volume of data · CPC title

• A61B8/0858

  involving measuring tissue layers, e.g. skin, interfaces · CPC title

• A61B8/12

  in body cavities or body tracts, e.g. by using catheters · CPC title

• G01S15/8909

  using a static transducer configuration · CPC title